[go: up one dir, main page]

EP3448399A4 - Méthode et système de caractérisation d'affections cutanées - Google Patents

Méthode et système de caractérisation d'affections cutanées Download PDF

Info

Publication number
EP3448399A4
EP3448399A4 EP17790288.9A EP17790288A EP3448399A4 EP 3448399 A4 EP3448399 A4 EP 3448399A4 EP 17790288 A EP17790288 A EP 17790288A EP 3448399 A4 EP3448399 A4 EP 3448399A4
Authority
EP
European Patent Office
Prior art keywords
related conditions
characterizing skin
characterizing
skin
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17790288.9A
Other languages
German (de)
English (en)
Other versions
EP3448399A1 (fr
Inventor
Zachary APTE
Jessica RICHMAN
Catalina Valdivia
Daniel Almonacid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3448399A1 publication Critical patent/EP3448399A1/fr
Publication of EP3448399A4 publication Critical patent/EP3448399A4/fr
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Theoretical Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP17790288.9A 2016-04-25 2017-04-25 Méthode et système de caractérisation d'affections cutanées Pending EP3448399A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662327126P 2016-04-25 2016-04-25
US201662327089P 2016-04-25 2016-04-25
US201662327048P 2016-04-25 2016-04-25
PCT/US2017/029470 WO2017189614A1 (fr) 2016-04-25 2017-04-25 Méthode et système de caractérisation d'affections cutanées

Publications (2)

Publication Number Publication Date
EP3448399A1 EP3448399A1 (fr) 2019-03-06
EP3448399A4 true EP3448399A4 (fr) 2020-05-13

Family

ID=60160002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17790288.9A Pending EP3448399A4 (fr) 2016-04-25 2017-04-25 Méthode et système de caractérisation d'affections cutanées

Country Status (5)

Country Link
EP (1) EP3448399A4 (fr)
CN (1) CN109152803B (fr)
AU (1) AU2017257785A1 (fr)
CA (1) CA3022294A1 (fr)
WO (1) WO2017189614A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973890B2 (en) 2016-09-13 2021-04-13 Allergan, Inc. Non-protein clostridial toxin compositions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3011046A4 (fr) 2013-06-18 2017-03-01 Prodermiq, Inc. Produits de soin pour la peau personnalisés et produits de soin personnels basés sur l'analyse de la flore cutanée
CN110753966A (zh) 2017-03-10 2020-02-04 普罗皮肤检测股份有限公司 基于皮肤菌群分析的定制化护肤产品和个人护理产品
WO2019191141A1 (fr) * 2018-03-26 2019-10-03 Prodermiq, Inc. Compositions et méthodes de traitement de l'acné
BR112020017257A2 (pt) * 2018-03-29 2020-12-22 Kimberly-Clark Worldwide, Inc. Sensor, artigo absorvente, e, método para indicar um potencial problema de pele ou gastrointestinal.
BR112023026959A2 (pt) * 2021-07-05 2024-03-12 Unilever Ip Holdings B V Métodos para avaliar uma composição cosmética, preparar um meio gravável para demonstrar o resultado da avaliação de uma composição cosmética e demonstrar o resultado da avaliação de uma composição cosmética
MX2024000047A (es) * 2021-07-05 2024-02-21 Unilever Ip Holdings B V Metodo para evaluar la piel.
CN118272552B (zh) * 2024-03-29 2025-02-14 美益添生物医药(武汉)有限公司 源于肠道菌群的白癜风检测标志物及其应用
CN118230890A (zh) * 2024-05-24 2024-06-21 西安润玉医疗科技有限公司 一种基于术后皮肤检测数据的产品匹配方法及系统

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142378A1 (fr) * 2012-03-17 2013-09-26 The Regents Of The University Of California Diagnostic rapide et traitements personnalisés de l'acné
WO2014205088A2 (fr) * 2013-06-18 2014-12-24 Prodermiq Produits de soin pour la peau personnalisés et produits de soin personnels basés sur l'analyse de la flore cutanée
WO2015070086A1 (fr) * 2013-11-07 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Utilisation d'acides nucléiques acellulaires pour l'analyse du microbiome chez l'homme et de ses composants
WO2015112352A2 (fr) * 2014-01-25 2015-07-30 uBiome, Inc. Procédé et système d'analyse du microbiome
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome
WO2016168350A1 (fr) * 2015-04-13 2016-10-20 uBiome, Inc. Procédé et système de caractérisation, de diagnostics et de traitements dérivés du microbiome pour des dermatoses
WO2017156031A1 (fr) * 2016-03-07 2017-09-14 uBiome, Inc. Procédé et système de caractérisation d'états pathologiques associés à la bouche

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120189621A1 (en) * 2011-01-21 2012-07-26 Yann Dean Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
CN107936121B (zh) * 2011-05-16 2022-01-14 埃泰美德(香港)有限公司 多特异性fab融合蛋白及其使用方法
US10131710B2 (en) * 2013-01-14 2018-11-20 Xencor, Inc. Optimized antibody variable regions
MX2015010843A (es) * 2013-02-26 2016-04-04 Roche Glycart Ag Moleculas biespecificas de union al antigeno que activan celulas t.
WO2014153164A1 (fr) * 2013-03-14 2014-09-25 The California Institute For Biomedical Research Conjugués d'anticorps et d'agent de ciblage et leurs utilisations

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142378A1 (fr) * 2012-03-17 2013-09-26 The Regents Of The University Of California Diagnostic rapide et traitements personnalisés de l'acné
WO2014205088A2 (fr) * 2013-06-18 2014-12-24 Prodermiq Produits de soin pour la peau personnalisés et produits de soin personnels basés sur l'analyse de la flore cutanée
WO2015070086A1 (fr) * 2013-11-07 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Utilisation d'acides nucléiques acellulaires pour l'analyse du microbiome chez l'homme et de ses composants
WO2015112352A2 (fr) * 2014-01-25 2015-07-30 uBiome, Inc. Procédé et système d'analyse du microbiome
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome
WO2016168350A1 (fr) * 2015-04-13 2016-10-20 uBiome, Inc. Procédé et système de caractérisation, de diagnostics et de traitements dérivés du microbiome pour des dermatoses
WO2017156031A1 (fr) * 2016-03-07 2017-09-14 uBiome, Inc. Procédé et système de caractérisation d'états pathologiques associés à la bouche

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973890B2 (en) 2016-09-13 2021-04-13 Allergan, Inc. Non-protein clostridial toxin compositions
US12144847B2 (en) 2016-09-13 2024-11-19 Allergan, Inc. Non-protein clostridial toxin compositions
US12171816B2 (en) 2016-09-13 2024-12-24 Allergan, Inc. Non-protein Clostridial toxin compositions

Also Published As

Publication number Publication date
AU2017257785A1 (en) 2018-11-08
CN109152803B (zh) 2022-09-23
WO2017189614A1 (fr) 2017-11-02
CN109152803A (zh) 2019-01-04
EP3448399A1 (fr) 2019-03-06
CA3022294A1 (fr) 2017-11-02

Similar Documents

Publication Publication Date Title
EP3507742A4 (fr) Système et procédé de caractérisation de plantes de la famille des cannabaceae
EP3635621A4 (fr) Système et procédé de désidentification d'image
EP3811316C0 (fr) Système et procédé de chaîne de blocs
EP3552137A4 (fr) Système et procédés de détection de logiciels malveillants avec chiffrement
EP3485435A4 (fr) Système et procédé d'apprentissage automatique de fonctions
EP3673345A4 (fr) Système et procédé pour suivi d'un dispositif distribué
EP3576707C0 (fr) Système et procédé de reconnaissance de l'intention d'un utilisateur
EP3697736C0 (fr) Système pour fournir des contenants marqués et procédé associé
EP3596960A4 (fr) Système de positionnement précis et procédé d'utilisation associé
EP3443683C0 (fr) Système et procédé pour une gestion de faisceau
EP3844553C0 (fr) Procédé et système d'estimation du regard
EP3349040C0 (fr) Procédé de navigation pour objets sous-marins et système de sa mise en oeuvre
EP3448399A4 (fr) Méthode et système de caractérisation d'affections cutanées
EP3503033C0 (fr) Système et procédé de suivi optique
EP3700606A4 (fr) Système et procédé de collecte de plasma
EP3308608C0 (fr) Système et procédé de suivi visuel
EP3589330A4 (fr) Méthodes et systèmes de modification d'adn
EP3622476A4 (fr) Système et procédé de traitement d'image
EP3469623A4 (fr) Système d'ionisation douce et son procédé d'utilisation
EP3422939A4 (fr) Procédé et système d'imagerie
EP3481290A4 (fr) Systèmes et procédés de détection d'un oedème
EP3454924A4 (fr) Système et procédé de dosage radiologique
EP3548440A4 (fr) Systèmes de traitement de fluide et procédés d'utilisation de ces derniers
EP3600549A4 (fr) Systèmes et procédés pour l'administration de radiothérapie
DE112018000901A5 (de) Verfahren und Vorrichtung zur Beatmung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181024

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: C12Q0001689000

A4 Supplementary search report drawn up and despatched

Effective date: 20200417

RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 17/00 20190101ALI20200408BHEP

Ipc: C12Q 1/689 20180101AFI20200408BHEP

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230905